CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...
Phase 3
Cleveland, Ohio, United States and 107 other locations
The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate...
Phase 2
Middleburg Heights, Ohio, United States and 22 other locations
The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate...
Phase 4
Cleveland, Ohio, United States and 4 other locations
patients with progressive metastatic castration-resistant prostate cancer (mCRPC).The following assessment of prostate cancer...
Phase 3
Middleburg Heights, Ohio, United States and 57 other locations
therapy in participants with metastatic castration resistant prostate cancer (mCRPC). There will be ten cohorts in this study: Coho...
Phase 1, Phase 2
Cleveland, Ohio, United States and 32 other locations
period and an additional 40-week safety extension period in men with prostate cancer, either metastatic castration-sensitive prostate...
Phase 1
Middleburg Heights, Ohio, United States and 16 other locations
optimal management of curable neurologic conditions. Breast cancer is the most common cancer in African-American women and Prostate...
Cleveland, Ohio, United States
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Cleveland, Ohio, United States and 388 other locations
plus docetaxel in participants with metastatic castration resistant prostate cancer (mCRPC), all participants will receive the doce...
Phase 3
Cleveland, Ohio, United States and 249 other locations
prednisone/prednisolone compared with placebo plus abiraterone and prednisone/prednisolone in participants with metastatic castrate-resistant prostate...
Phase 3
Cleveland, Ohio, United States and 183 other locations
Clinical trials
Research sites
Resources
Legal